Literature DB >> 10510741

Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferase.

W Zhang1, H Parentau, R L Greenly, C A Metz, S Aggarwal, I W Wainer, T S Tracy.   

Abstract

Protein-calorie malnutrition (PCM) can develop both from inadequate food intake and as a consequence of diseases such as cancer and AIDS. Several studies have shown that PCM can alter drug clearance but little information is available on the effect of PCM on individual cytochrome P450 isoforms and phase II conjugation enzymes. The aim of the present study was to begin a systematic evaluation of the effect of PCM on the activity of individual drug metabolizing enzymes in a rat model of PCM. Control and PCM rats received isocaloric diets which contained either 21% or 5% (deficient) protein. After 3 weeks, the animals were sacrificed and microsomal and cytosolic fractions prepared. Ethoxyresorufin O-deethylation (EROD), chlorzoxazone 6-hydroxylation, dextromethorphan N- and O-demethylation and 1-chloro-2,4-dinitrobenzene (CDNB) conjugation were used as measures of CYP1A, CYP2E1, CYP3A2, CYP2D1 and glutathione S-transferase (GST) activity, respectively. Additionally, NADPH-cytochrome P450 reductase activity was measured in the liver microsomes. PCM significantly reduced the maximum velocity (Vmax) of all model reactions studied. However, differential effects were observed with respect to K(m) values of the reactions. The K(m) values for EROD and dextromethorphan N-demethylation were significantly increased in PCM animals, whereas the K(m) values for chlorzoxazone 6-hydroxylation and dextromethorphan O-demethylation were decreased. In contrast, the K(m) value for CDNB conjugation was unchanged. When NADPH-cytochrome P450 reductase activity was compared, a 29% reduction in reductase activity was noted in PCM animals as compared to controls. Thus, it appears that PCM decreases the overall activity of certain phase I and phase II metabolism enzymes in rat liver while exhibiting differential effects on K(m). Furthermore, this reduction in activity may be due in part to diminished activity of cytochrome P450 reductase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510741     DOI: 10.1007/BF03190359

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  38 in total

1.  Drug metabolism in malnourished children: a study with antipyrine.

Authors:  M Homeida; Z A Karrar; C J Roberts
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

2.  Rapid and sensitive high-performance liquid chromatographic assay for 6-hydroxychlorzoxazone and chlorzoxazone in liver microsomes.

Authors:  S V Chittur; T S Tracy
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-06-06

3.  Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity.

Authors:  P Dayer; T Leemann; R Striberni
Journal:  Clin Pharmacol Ther       Date:  1989-01       Impact factor: 6.875

4.  Effects of dietary protein deficiency on the conjugation of foreign compounds in rat liver.

Authors:  G C Wood; B G Woodcock
Journal:  J Pharm Pharmacol       Date:  1970-12       Impact factor: 3.765

5.  Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation.

Authors:  H Yamazaki; Z Guo; F P Guengerich
Journal:  Drug Metab Dispos       Date:  1995-03       Impact factor: 3.922

6.  Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction.

Authors:  J A Peterson; R E Ebel; D H O'Keeffe; T Matsubara; R W Estabrook
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

7.  Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene.

Authors:  M D Burke; R T Mayer
Journal:  Drug Metab Dispos       Date:  1974 Nov-Dec       Impact factor: 3.922

8.  Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.

Authors:  N Buchanan; C Eyberg; M D Davis
Journal:  Am J Clin Nutr       Date:  1979-12       Impact factor: 7.045

Review 9.  Nutritional support of the medical oncology patient.

Authors:  R T Chlebowski
Journal:  Hematol Oncol Clin North Am       Date:  1991-02       Impact factor: 3.722

10.  Purified liver microsomal NADPH-cytochrome P-450 reductase. Spectral characterization of oxidation-reduction states.

Authors:  J L Vermilion; M J Coon
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

View more
  3 in total

1.  Modulation of Kupffer cells on hepatic drug metabolism.

Authors:  Hong Ding; Jing Tong; Shi-Cheng Wu; Deng-Ke Yin; Xian-Fen Yuan; Jian-Yuan Wu; Jun Chen; Gang-Gang Shi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 2.  Paracetamol: a focus for the general pediatrician.

Authors:  Pierluigi Marzuillo; Stefano Guarino; Egidio Barbi
Journal:  Eur J Pediatr       Date:  2013-12-28       Impact factor: 3.183

3.  Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review.

Authors:  Luka Verrest; Erica A Wilthagen; Jos H Beijnen; Alwin D R Huitema; Thomas P C Dorlo
Journal:  Clin Pharmacokinet       Date:  2021-06-01       Impact factor: 5.577

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.